Alliance for mRNA Medicines
Become a Member

BioCurie

Irene Rombel, PhD, MBA

CEO, President, and Co-Founder
BioCurie
  • BioCurie is pioneering mechanistic AI (mAI) software to transform process development and manufacturing for genomic medicines, including RNA and LNP-based therapies.
  • The mAI BioCurie™ digital platform enables biopharma to quickly improve product quality, yield, reproducibility, scalability, and cost across development, scale-up, tech transfer, and commercial production.
  • BioCurie’s technology gives scientists and engineers deeper insight into complex manufacturing systems and support more robust, data-driven decision-making for next-generation genomic medicine production.
  • BioCurie is led by CEO and Co-Founder, Dr. Irene Rombel, with scientific leadership from Chief Scientist and Co-Founder, Prof. Richard Braatz, Director of the MIT Center for Continuous mRNA Manufacturing, and word leader in advanced data modeling, process control, and AI/ML for biomanufacturing.